Session - Living Liver Donar 2OBJECTIVE: Liver grafts from living donors are probably small-for-size for adult recipients. lnjury after reperfusion is common but the degree and mechanism of injury remains unknown. The aim of this study is to assess the degree of injury after reperfusion in living donor liver transplantation in relation to graft size. PATIENTS AND METHODS: From May 8 to Nov 20, 2000, we performed 16 living donor liver transplantation using right lobe graft. Portal pressure was measured continuously before and after reperfusion. Liver biopsies were taken for endothelin-l (ET-1) mRNA detection using quantitative real time PCR and electron microscope examination. Portal vein blood samples were taken for the measurement of plas...
Abstract Background: In this study, we have used the middle hepatic vein with the right lobe, an...
Background:To treat small-for-size syndrome (SFSS) after living donor liver transplantation (LDLT), ...
Small-for-size syndrome (SFSS) has an incidence between 0 and 43% in small-for-size graft (SFSG) adu...
Objective: To investigate the degree and mechanism of hepatic sinusoidal injury in different graft s...
Background: Damage to a small-for-size liver graft after reperfusion is frequently observed but the ...
BackgroundEarly allograft dysfunction (EAD) after living donor liver transplantation (LDLT) has ofte...
Objective: To investigate whether low-dose nitric oxide donor FK 409 could attenuate small-for-size ...
Background: The discrepancy between demand and supply for liver transplants (LT) has led to an incre...
Background: The discrepancy between demand and supply for liver transplants (LT) has led to an incre...
The middle hepatic vein may be included in right liver living donor liver transplantation (LDLT) to ...
This journal suppl. entitled: Supplement: The International Liver Transplantation Society: 15th Annu...
The issue of small-for-size graft (SFSG) containing the middle hepatic vein in right liver living do...
AbstractBackgroundSometimes even in adequate graft to recipient weight ratio (GRWR) settings and aft...
AIM: To investigate middle hepatic vein (MHV) management in adult living donor liver transplantation...
Adult-to-adult living donors and recipients were studied to characterize patterns of liver growth an...
Abstract Background: In this study, we have used the middle hepatic vein with the right lobe, an...
Background:To treat small-for-size syndrome (SFSS) after living donor liver transplantation (LDLT), ...
Small-for-size syndrome (SFSS) has an incidence between 0 and 43% in small-for-size graft (SFSG) adu...
Objective: To investigate the degree and mechanism of hepatic sinusoidal injury in different graft s...
Background: Damage to a small-for-size liver graft after reperfusion is frequently observed but the ...
BackgroundEarly allograft dysfunction (EAD) after living donor liver transplantation (LDLT) has ofte...
Objective: To investigate whether low-dose nitric oxide donor FK 409 could attenuate small-for-size ...
Background: The discrepancy between demand and supply for liver transplants (LT) has led to an incre...
Background: The discrepancy between demand and supply for liver transplants (LT) has led to an incre...
The middle hepatic vein may be included in right liver living donor liver transplantation (LDLT) to ...
This journal suppl. entitled: Supplement: The International Liver Transplantation Society: 15th Annu...
The issue of small-for-size graft (SFSG) containing the middle hepatic vein in right liver living do...
AbstractBackgroundSometimes even in adequate graft to recipient weight ratio (GRWR) settings and aft...
AIM: To investigate middle hepatic vein (MHV) management in adult living donor liver transplantation...
Adult-to-adult living donors and recipients were studied to characterize patterns of liver growth an...
Abstract Background: In this study, we have used the middle hepatic vein with the right lobe, an...
Background:To treat small-for-size syndrome (SFSS) after living donor liver transplantation (LDLT), ...
Small-for-size syndrome (SFSS) has an incidence between 0 and 43% in small-for-size graft (SFSG) adu...